1992
DOI: 10.1016/0018-506x(92)90020-v
|View full text |Cite
|
Sign up to set email alerts
|

An assessment of agonist/antagonist effects of tamoxifen in the female mouse brain*1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
1

Year Published

1993
1993
2019
2019

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(12 citation statements)
references
References 23 publications
1
10
1
Order By: Relevance
“…These results suggest that treatment with PM-100 affects the estrous cycle and mating behavior of female mice and subsequently results in reduced pregnancy rates and litter sizes. Previous studies have shown that treatment with soy supplement and tamoxifen (antiestrogen) suppresses lordosis in estrogen-and progesterone-primed female rats [32][33][34][35]. As mentioned above, treatment with PM-100 reduced the serum FSH and LH levels of the mice, and we suspected that there was a subsequent reduction in the estrogen level, although we did not determine the level of this hormone in the current study.…”
Section: Discussioncontrasting
confidence: 45%
“…These results suggest that treatment with PM-100 affects the estrous cycle and mating behavior of female mice and subsequently results in reduced pregnancy rates and litter sizes. Previous studies have shown that treatment with soy supplement and tamoxifen (antiestrogen) suppresses lordosis in estrogen-and progesterone-primed female rats [32][33][34][35]. As mentioned above, treatment with PM-100 reduced the serum FSH and LH levels of the mice, and we suspected that there was a subsequent reduction in the estrogen level, although we did not determine the level of this hormone in the current study.…”
Section: Discussioncontrasting
confidence: 45%
“…The estrogenic effects of tamoxifen that have been noted in other tissues have been attributed to effects on estrogen receptor f unction that involve actions other than those mediated by estrogen receptor-ERE interactions (Webb et al, 1995) possibly via AP-1 sites. Tamoxifen has been shown to block the actions of estrogen in brain, both on estrogen-induced sexual behavior and induction of progesterone receptor mRNA (McKenna et al, 1992). ICI 182,780 interferes with activated hormone-receptor complex binding to DNA by preventing dimerization and nuclear translocation.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, in the United States, it is estimated that based on year 2000 census data more than 2 million women could benefit from prophylactic use of TAM (Freedman et al, 2003), highlighting the importance of understanding the potential neurocognitive side effects of this agent. TAM is known to have both agonist and antagonist effects in the periphery and in the brain (McKenna et al, 1992). It has also been reported to influence the production of proinflammatory cytokines (IL-1, IL-6, and TNF) that are associated with cognitive dysfunction (Järvinen et al, 1996).…”
Section: Hormonal Therapymentioning
confidence: 99%